CAS 2445259-99-2

Reozalimab

CAS: 2445259-99-2

Reozalimab (LY3434172) is a bispecific monoclonal antibody targeting PD-1/PD-L1, antitumour and enhances T-cell activation in vitro.

Purity: 95% - 98.1% (SDS-PAGE); 96.2% (SEC-HPLC)

Color and Shape: Liquid

Molecular weight: 144.16 kDa

Ref: TM-T80617